Airtime: ET
Debating whether California should sell bonds to fund the controversial research, with Sigrid Fry-Revere, Cato director, bioethics studies; John Hlinko, StemPAC founder and CNBC's Carl Quintanilla
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
CNBC's Bill Griffeth looks ahead to next week's top business and financial stories.
The top headlines this hour, with CNBC's Sri Jegarajah.